JPWO2021011881A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021011881A5
JPWO2021011881A5 JP2022502510A JP2022502510A JPWO2021011881A5 JP WO2021011881 A5 JPWO2021011881 A5 JP WO2021011881A5 JP 2022502510 A JP2022502510 A JP 2022502510A JP 2022502510 A JP2022502510 A JP 2022502510A JP WO2021011881 A5 JPWO2021011881 A5 JP WO2021011881A5
Authority
JP
Japan
Prior art keywords
pgi
phosphate
seq
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022502510A
Other languages
Japanese (ja)
Other versions
JP2022541471A (en
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/042562 external-priority patent/WO2021011881A1/en
Publication of JP2022541471A publication Critical patent/JP2022541471A/en
Publication of JPWO2021011881A5 publication Critical patent/JPWO2021011881A5/ja
Pending legal-status Critical Current

Links

Claims (19)

ヘキソースの調製のための固定化酵素組成物であって、少なくとも1つの担体または担体の混合物に固定化された以下の酵素のうちの、少なくとも2つ、少なくとも3つ、少なくとも4つ、少なくとも5つ、少なくとも6つの担体、少なくとも7つ、または少なくとも8つを含む、固定化酵素組成物:
a)αグルカンホスホリラーゼ(αGP)、ホスホグルコムターゼ(PGM)、および任意選択的に、1,4-グルカントランスフェラーゼ(4-GT)、ならびに
b)以下から選択される酵素の組み合わせの中からの酵素:
(i)タガトースを調製するための、ホスホグルコイソメラーゼ(PGI)、フルクトース-6-リン酸エピメラーゼ(F6PE)、およびタガトース-6-リン酸ホスファターゼ(T6PP)、
(ii)アルロースを調製するための、ホスホグルコイソメラーゼ(PGI)、ピスコース-6-リン酸エピメラーゼ(P6PE)、およびピコース-6-リン酸ホスファターゼ(P6PP)、
(iii)アロースを調製するための、ホスホグルコイソメラーゼ(PGI)、P6PE、アロース-6-リン酸イソメラーゼ(A6PI)、およびアロース-6-リン酸ホスファターゼ(A6PP)、
(iv)マンノースを調製するための、ホスホグルコイソメラーゼ(PGI)、マンノース-6-リン酸イソメラーゼ(M6PI)またはホスホグルコース/ホスホマンノースイソメラーゼ(PGPMI)、およびマンノース6-リン酸ホスファターゼ(M6PP)、
(v)ガラクトースを調製するための、ホスホグルコイソメラーゼ(PGI)、F6PE、ガラクトース6-リン酸イソメラーゼ(Gal6PI)、およびガラクトース6-リン酸ホスファターゼ(Gal6PP)、
(vi)フルクトースを調製するための、PGIおよびフルクトース6-リン酸ホスファターゼ(F6PP)、
(vii)アルトロースを調製するための、PGI、P6PE、アルトロース6-リン酸イソメラーゼ(Alt6PI)、およびアルトロース6-リン酸ホスファターゼ(Alt6PP)、
(viii)タロースを調製するための、PGI、F6PE、タロース6-リン酸イソメラーゼ(Tal6PI)、およびタロース6-リン酸ホスファターゼ(Tal6PP)、
(ix)ソルボースを調製するための、PGI、F6PE、ソルボース6-リン酸エピメラーゼ(S6PE)、およびソルボース6-リン酸ホスファターゼ(S6PP)、
(x)グロースを調製するための、PGI、F6PE、S6PE、グロース6-リン酸イソメラーゼ(Gul6PI)、およびグロース6-リン酸ホスファターゼ(Gul6PP)、
(xi)イドースを調製するための、PGI、F6PE、S6PE、イドース6-リン酸イソメラーゼ(I6PI)、およびイドース6-リン酸ホスファターゼ(I6PP)、ならびに
(xii)イノシトールを調製するための、イノシトール3-リン酸シンターゼ(IPS)およびイノシトールモノホスファターゼ(IMP)。
An immobilized enzyme composition for the preparation of hexoses, wherein at least two, at least three, at least four, at least five of the following enzymes immobilized on at least one carrier or mixture of carriers: , at least 6 carriers, at least 7, or at least 8:
a) alpha glucan phosphorylase (αGP), phosphoglucomutase (PGM), and optionally 1,4-glucan transferase (4-GT), and b) an enzyme from among a combination of enzymes selected from :
(i) phosphoglucoisomerase (PGI), fructose-6-phosphate epimerase (F6PE), and tagatose-6-phosphate phosphatase (T6PP) for preparing tagatose;
(ii) phosphoglucoisomerase (PGI), picose-6-phosphate epimerase (P6PE), and picose-6-phosphate phosphatase (P6PP) for the preparation of allulose;
(iii) phosphoglucoisomerase (PGI), P6PE, allose-6-phosphate isomerase (A6PI), and allose-6-phosphate phosphatase (A6PP) for the preparation of allose;
(iv) phosphoglucoisomerase (PGI), mannose-6-phosphate isomerase (M6PI) or phosphoglucose/phosphomannose isomerase (PGPMI), and mannose 6-phosphate phosphatase (M6PP) for the preparation of mannose;
(v) phosphoglucoisomerase (PGI), F6PE, galactose 6-phosphate isomerase (Gal6PI), and galactose 6-phosphate phosphatase (Gal6PP) for the preparation of galactose;
(vi) PGI and fructose 6-phosphate phosphatase (F6PP) for the preparation of fructose;
(vii) PGI, P6PE, altrose 6-phosphate isomerase (Alt6PI), and altrose 6-phosphate phosphatase (Alt6PP) for the preparation of altrose;
(viii) PGI, F6PE, talose 6-phosphate isomerase (Tal6PI), and talose 6-phosphate phosphatase (Tal6PP) for the preparation of talose;
(ix) PGI, F6PE, sorbose 6-phosphate epimerase (S6PE), and sorbose 6-phosphate phosphatase (S6PP) for the preparation of sorbose;
(x) PGI, F6PE, S6PE, gulose 6-phosphate isomerase (Gul6PI), and gulose 6-phosphate phosphatase (Gul6PP) for preparing gulose;
(xi) PGI, F6PE, S6PE, idose 6-phosphate isomerase (I6PI), and idose 6-phosphate phosphatase (I6PP) to prepare idose, and (xii) inositol 3 to prepare inositol - phosphate synthase (IPS) and inositol monophosphatase (IMP).
前記酵素の総重量に対する各酵素の重量(w/w)%が、0.1%~40%の範囲である、請求項1に記載の固定化酵素組成物。 2. The immobilized enzyme composition of claim 1, wherein the weight (w/w) % of each enzyme relative to the total weight of said enzymes ranges from 0.1% to 40%. 10~30%(αGP)、0~10%(4GT)、10~30%(PGM)、および存在する場合、0.1~10%(PGI)を含む、請求項1または2に記載の固定化酵素組成物。 10-30% (αGP), 0-10% (4GT), 10-30% (PGM) and, if present, 0.1-10% (PGI). enzyme composition. タガトースを調製するために、PGI、F6PE、およびT6PPをさらに含む、請求項3に記載の固定化酵素組成物。 4. The immobilized enzyme composition of claim 3 , further comprising PGI, F6PE, and T6PP to prepare tagatose. 前記酵素の総重量に対する各酵素の重量(w/w)%が、10~30%(αGP)、0~10%(4GT)、10~30%(PGM)、0.1~10%(PGI)、15~35%(F6PE)、およびT6PP(25~45%)であり、前記組成物中の酵素の総重量が、前記酵素の総重量に対して、合計100w/w%である、請求項4に記載の固定化酵素組成物。 The weight (w/w)% of each enzyme relative to the total weight of the enzyme is 10-30% (αGP), 0-10% (4GT), 10-30% (PGM), 0.1-10% (PGI ), 15-35% (F6PE), and T6PP (25-45%), wherein the total weight of enzymes in said composition totals 100% w/w relative to the total weight of said enzymes. Item 5. The immobilized enzyme composition according to item 4. 前記αGPが、配列番号1のアミノ酸配列、またはその断片を含み、
前記4-GTが、配列番号6のアミノ酸配列、またはその断片を含み、
前記PGMが、配列番号2のアミノ酸配列、またはその断片を含み、
前記PGIが、配列番号3のアミノ酸配列、またはその断片を含み、
前記F6PEが、配列番号4のアミノ酸配列、またはその断片を含み、および
前記T6PPが、配列番号5のアミノ酸配列、またはその断片を含む、
請求項5に記載の固定化酵素組成物。
the αGP comprises the amino acid sequence of SEQ ID NO: 1, or a fragment thereof;
the 4-GT comprises the amino acid sequence of SEQ ID NO: 6, or a fragment thereof;
the PGM comprises the amino acid sequence of SEQ ID NO: 2, or a fragment thereof;
the PGI comprises the amino acid sequence of SEQ ID NO: 3, or a fragment thereof;
said F6PE comprises the amino acid sequence of SEQ ID NO: 4, or a fragment thereof, and
wherein said T6PP comprises the amino acid sequence of SEQ ID NO: 5, or a fragment thereof;
6. The immobilized enzyme composition of claim 5.
アルロースを調製するために、PGI、P6PE、およびP6PPをさらに含む、請求項3に記載の固定化酵素組成物。 4. The immobilized enzyme composition of claim 3 , further comprising PGI, P6PE, and P6PP to prepare allulose. 前記酵素の総重量に対する各酵素の重量(w/w)%が、10~30%(αGP)、0~10%(4GT)、10~30%(PGM)、0.1~10%(PGI)、0.1~10%(P6PE)、および(45~65%)P6PPであり、前記組成物中の酵素の総重量が、前記酵素の総重量に対して、合計100w/w%である、請求項7に記載の固定化酵素組成物。 The weight (w/w)% of each enzyme relative to the total weight of the enzyme is 10-30% (αGP), 0-10% (4GT), 10-30% (PGM), 0.1-10% (PGI ), 0.1-10% (P6PE), and (45-65%) P6PP, wherein the total weight of enzymes in the composition totals 100% w/w based on the total weight of the enzymes. 8. The immobilized enzyme composition of claim 7. 前記αGPが、配列番号1のアミノ酸配列、またはその断片を含み、
前記4-GTが、配列番号6のアミノ酸配列を含み、
前記PGMが、配列番号2のアミノ酸配列を含み、
前記PGIが、配列番号3のアミノ酸配列を含み、
前記P6PEが、配列番号7のアミノ酸配列を含み、および
前記P6PPが、配列番号8のアミノ酸配列を含む、
請求項8に記載の固定化酵素組成物。
the αGP comprises the amino acid sequence of SEQ ID NO: 1, or a fragment thereof;
the 4-GT comprises the amino acid sequence of SEQ ID NO: 6;
the PGM comprises the amino acid sequence of SEQ ID NO: 2;
the PGI comprises the amino acid sequence of SEQ ID NO: 3;
said P6PE comprises the amino acid sequence of SEQ ID NO: 7, and
wherein the P6PP comprises the amino acid sequence of SEQ ID NO:8;
9. The immobilized enzyme composition of claim 8.
前記担体の重量に対する前記酵素の総重量(W/Wが、2.5%~12.5%である、請求項1~9のいずれか一項に記載の固定化酵素組成物。 The immobilized enzyme composition according to any one of claims 1 to 9, wherein the total weight ( W/W ) % of said enzyme relative to the weight of said carrier is between 2.5% and 12.5%. 前記担体が、弱塩基性陰イオン交換樹脂である、請求項1~10のいずれか一項に記載の固定化酵素組成物。 The immobilized enzyme composition of any one of claims 1-10, wherein the carrier is a weakly basic anion exchange resin. 前記担体が、フェノールホルムアルデヒド重縮合体を含む、請求項11に記載の固定化酵素組成物。 12. The immobilized enzyme composition of claim 11, wherein said carrier comprises phenol formaldehyde polycondensate. 前記担体が、三級アミン官能基を含み、前記組成物が、任意選択的に、DUOLITE(商標)A568である、請求項11または12に記載の固定化酵素組成物。 13. The immobilized enzyme composition of claim 11 or 12, wherein said carrier comprises a tertiary amine functional group and said composition is optionally DUOLITE(TM) A568. 前記担体が、二級アミン官能基を含み、前記組成物が、任意選択的に、DUOLITE(商標)PWA7である、請求項11または12に記載の固定化酵素組成物。 13. The immobilized enzyme composition of claim 11 or 12, wherein the carrier comprises secondary amine functional groups and the composition is optionally DUOLITE(TM) PWA7. 前記担体が、Hisタグ親和性樹脂を含む、請求項1~10のいずれか一項に記載の固定化酵素組成物。 The immobilized enzyme composition of any one of claims 1-10, wherein the carrier comprises a His-tag affinity resin. 好適な反応条件下で、デンプン誘導体を請求項1~15のいずれか一項に記載の固定化酵素組成物と接触させて、前記デンプン誘導体をヘキソースに変換するステップを含む、糖からヘキソースを調製するための酵素プロセス。 Contacting a starch derivative with an immobilized enzyme composition according to any one of claims 1 to 15 under suitable reaction conditions to convert said starch derivative to a hexose. enzymatic process to 前記プロセスのステップが、約40℃~約85℃の範囲の温度で、約5.0~約8.0の範囲のpHで、および/または約0.5時間~約48時間行われる、請求項16に記載のプロセス。 wherein said process steps are carried out at temperatures ranging from about 40° C. to about 85° C., pH ranging from about 5.0 to about 8.0, and/or from about 0.5 hours to about 48 hours. 17. The process of paragraph 16 . 前記プロセスのステップが、単一のバイオ反応器、直列に配置された複数のバイオ反応器、または並列に配置された複数のバイオ反応器で行われる、請求項16または17に記載のプロセス。 18. The process of claim 16 or 17 , wherein the process steps are performed in a single bioreactor, multiple bioreactors arranged in series, or multiple bioreactors arranged in parallel. 前記プロセスのステップが、約0.1mM~約150mMのリン酸濃度で、ATP不含、NAD(P)(H)不含で行われ、前記リン酸が、酵素カスケード反応内で再利用され、および/または前記プロセスの少なくとも1つのステップが、非常にエネルギー的に有利な化学反応を伴う、請求項1618のいずれか一項に記載のプロセス。 the steps of the process are performed at a phosphate concentration of about 0.1 mM to about 150 mM, ATP-free, NAD(P)(H)-free, wherein the phosphate is recycled within the enzymatic cascade reaction; and /or at least one step of said process involves a highly energetically favorable chemical reaction.
JP2022502510A 2019-07-17 2020-07-17 Immobilized enzyme composition for production of hexose Pending JP2022541471A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962875321P 2019-07-17 2019-07-17
US62/875,321 2019-07-17
US201962924323P 2019-10-22 2019-10-22
US62/924,323 2019-10-22
PCT/US2020/042562 WO2021011881A1 (en) 2019-07-17 2020-07-17 Immobilized enzyme compositions for the production of hexoses

Publications (2)

Publication Number Publication Date
JP2022541471A JP2022541471A (en) 2022-09-26
JPWO2021011881A5 true JPWO2021011881A5 (en) 2023-07-11

Family

ID=74209943

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022502510A Pending JP2022541471A (en) 2019-07-17 2020-07-17 Immobilized enzyme composition for production of hexose

Country Status (9)

Country Link
EP (1) EP3999636A4 (en)
JP (1) JP2022541471A (en)
KR (1) KR20220035460A (en)
CN (1) CN114599786A (en)
BR (1) BR112022000699A2 (en)
CA (1) CA3143852A1 (en)
CO (1) CO2022001348A2 (en)
MX (1) MX2022000381A (en)
WO (1) WO2021011881A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2023008520A (en) * 2021-02-02 2023-09-25 Bonumose Inc Enzymatic enrichment of food ingredients for sugar reduction.
CN112708614A (en) * 2021-02-05 2021-04-27 江南大学 Preparation method and application of co-immobilized double enzymes
CN112760317B (en) * 2021-04-07 2021-08-24 中国科学院天津工业生物技术研究所 Method for producing tagatose by biomimetic silicified microcapsule immobilized multienzyme

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4778418B2 (en) * 2003-03-06 2011-09-21 ヴェレニウム コーポレイション Amylase, nucleic acid encoding the same, and production and use thereof
US20080148432A1 (en) * 2005-12-21 2008-06-19 Mark Scott Abad Transgenic plants with enhanced agronomic traits
CA2599577A1 (en) * 2005-03-04 2006-09-14 Verenium Corporation Nucleic acids and proteins and methods for making and using them
EP2540831A3 (en) * 2006-08-17 2013-04-10 Monsanto Technology, LLC Transgenic plants with enhanced agronomic traits
EP2175714A4 (en) * 2007-07-10 2011-01-26 Monsanto Technology Llc Transgenic plants with enhanced agronomic traits
ES2958266T3 (en) * 2014-01-31 2024-02-06 Enginzyme Ab Procedure to catalyze an enzyme-catalyzed reaction
BR112019012215A2 (en) * 2016-12-14 2019-11-12 Bonumose Llc enzymatic production of d-alulose
DE102017002252A1 (en) * 2017-03-08 2018-09-13 André Pick Enzymatic process for the production of fructose
KR20190128681A (en) * 2017-03-13 2019-11-18 보너모스 엘엘씨 Enzymatic Preparation of Hexose
KR20180111667A (en) * 2017-03-31 2018-10-11 씨제이제일제당 (주) A composition for preparing tagatose and Methods for producing tagatose using The Same
EP3867393A4 (en) * 2018-10-19 2022-08-24 Bonumose, Inc. Enzymatic production of tagatose
WO2020092315A1 (en) * 2018-10-29 2020-05-07 Bonumose Llc Enzymatic production of hexoses
US20220127653A1 (en) * 2019-02-12 2022-04-28 Bonumose, Inc. Enzymatic production of mannose
CN112626060B (en) * 2019-10-09 2022-05-13 中国科学院天津工业生物技术研究所 Immobilized multienzyme system for producing inositol and method for producing inositol

Similar Documents

Publication Publication Date Title
Uchida et al. 9 Microbial Ribonucleases with Special Reference to RNases T1, T2, N1, and U2
Lohrmann et al. Prebiotic activation processes
KR102581107B1 (en) Enzymatic production of D-allulose
US5874261A (en) Method for the purification of glycosyltransferases
US20210381014A1 (en) Enzymatic production of hexoses
CA3143852A1 (en) Immobilized enzyme compositions for the production of hexoses
US20220127653A1 (en) Enzymatic production of mannose
Card et al. Chemoenzymic syntheses of fructose-modified sucroses via multienzyme systems. Some topographical aspects of the binding of sucrose to a sucrose carrier protein
JPWO2021011881A5 (en)
JP3032289B2 (en) Multifunctional enzyme and inducible 2 ', 3'-dideoxyribofuranoside triphosphate
US6569649B2 (en) Compositions and methods for saccharide synthesis
US20240200109A9 (en) Immobilized enzyme compositions for the production of hexoses
Bryant et al. Phosphorothioate substrates for T4 RNA ligase
KR101765684B1 (en) Composition for producing phosphorylated tagatose from phosphorylated fructose derivative comprising Fructose 1,6-bisphosphate aldolase from Caldicellulosiruptor sp. as effective component
JPS6350359B2 (en)
Lucas-Lenard et al. The inhibition of polynucleotide phosphorylase by certain substrate analogues
JPH02177891A (en) Method for synthesizing cytidine-5'-monophosphosialate by conjugated enzymic reaction
CN114774495B (en) Double-enzyme co-immobilization synthesis method of uridine diphosphate-N-acetamido glucose
CN114703242B (en) Double-enzyme co-immobilization synthesis method of uridine diphosphate-N-acetamido glucose and derivatives thereof
JPH0759587A (en) Production of saccharide and complex saccharide
KR20180008256A (en) Composition for producing phosphorylated tagatose from phosphorylated fructose derivative comprising Fructose 1,6-bisphosphate aldolase from Caldicellulosiruptor sp. as effective component
US20030130175A1 (en) Saccharide compositions, methods and apparatus for their synthesis
RU2021115272A (en) ENZYMATIC PRODUCTION OF HEXOSES
CN117157398A (en) Enzymatic enrichment of blood-reducing food ingredients
JPS62134096A (en) Synthesis of n-acetyllactosamine by composite enzyme